Previous studies have also shown that CYP3A5 suppresses HCC pathogenesis and metastasis through the modulation of the mTORC2/Akt signaling cascade, serving as a prognostic biosignature [54, 55]. Here, AKT1 is linked to hepatocellular carcinoma.